Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nicotine patch does not increase risk of adverse events among CHD patients -- study.

This article was originally published in The Tan Sheet

Executive Summary

NICOTINE PATCH THERAPY DOES NOT INCREASE CARDIAC EVENTS incidence in patients with cardiac disease, according to a study conducted by Anne Joseph, MD, University of Minnesota, et al., published in the Dec. 12 issue of The New England Journal of Medicine. The authors determined that "serious adverse events are common and occur at nearly the same rate among subjects with cardiovascular disease who try to quit smoking, regardless of whether they use transdermal nicotine or placebo."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel